[{"id":"516a1481-2de8-44ea-b356-947a33ffc479","acronym":"","url":"https://clinicaltrials.gov/study/NCT06017258","created_at":"2023-08-30T14:08:49.071Z","updated_at":"2024-07-02T16:35:22.406Z","phase":"Phase 1","brief_title":"A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia","source_id_and_acronym":"NCT06017258","lead_sponsor":"Memorial Sloan Kettering Cancer Center","biomarkers":" FLT3 • IDH1 • IDH2 • IL18 • CD37","pipe":" | ","alterations":" FLT3-ITD mutation • IDH1 mutation • IDH2 mutation • CD37 expression","tags":["FLT3 • IDH1 • IDH2 • IL18 • CD37"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e FLT3-ITD mutation • IDH1 mutation • IDH2 mutation • CD37 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e CD371-YSNVZ-IL18 CAR T cells"],"overall_status":"Recruiting","enrollment":" Enrollment 6","initiation":"Initiation: 08/22/2023","start_date":" 08/22/2023","primary_txt":" Primary completion: 08/22/2026","primary_completion_date":" 08/22/2026","study_txt":" Completion: 08/22/2026","study_completion_date":" 08/22/2026","last_update_posted":"2024-01-24"}]